Suppr超能文献

尿嘧啶类似物对1型人类免疫缺陷病毒及其逆转录酶的作用。

Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.

作者信息

Piras G, Dutschman G E, Im G J, Pan B C, Chu S H, Cheng Y C

机构信息

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

出版信息

Antimicrob Agents Chemother. 1995 Feb;39(2):539-41. doi: 10.1128/AAC.39.2.539.

Abstract

Three structural analogs of 5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil (E-BPU) inhibited human immunodeficiency virus type 1 (HIV-1) replication without cytotoxicity in vitro and were more potent than azidothymidine and were as potent as E-BPU. The target of these compounds is HIV-1 reverse transcriptase. Reverse transcriptases resistant to nevirapine (tyrosine at position 181 to cysteine) and TIBO R82150 (leucine at position 100 to isoleucine) are cross resistant to E-BPU analogs. Nevirapine- or TIBO R82150-resistant HIV-1 were cross resistant to E-BPU analogs but were inhibited at concentrations 11- to 135-fold lower than the cytotoxic doses.

摘要

5-乙基-1-苄氧甲基-6-(苯硫基)尿嘧啶(E-BPU)的三种结构类似物在体外可抑制人类免疫缺陷病毒1型(HIV-1)复制且无细胞毒性,其效力比叠氮胸苷更强,与E-BPU效力相当。这些化合物的作用靶点是HIV-1逆转录酶。对奈韦拉平(第181位酪氨酸突变为半胱氨酸)和TIBO R82150(第100位亮氨酸突变为异亮氨酸)耐药的逆转录酶对E-BPU类似物存在交叉耐药性。对奈韦拉平或TIBO R82150耐药的HIV-1对E-BPU类似物也存在交叉耐药性,但在比细胞毒性剂量低11至135倍的浓度下受到抑制。

相似文献

本文引用的文献

2
HIV resistance to reverse transcriptase inhibitors.人类免疫缺陷病毒对逆转录酶抑制剂的耐药性。
Biochem Pharmacol. 1994 Jan 20;47(2):155-69. doi: 10.1016/0006-2952(94)90001-9.
9
DNA polymerases versus HIV reverse transcriptase in AIDS therapy.
Ann N Y Acad Sci. 1990;616:217-23. doi: 10.1111/j.1749-6632.1990.tb17842.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验